The Sulfonamides
- 27 October 1960
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 263 (17) , 842-849
- https://doi.org/10.1056/nejm196010272631707
Abstract
Sulfamethoxypyridazine¶Sulfamethoxypyridazine (3-sulfanilamido-6-methoxypyridazine) is a "long acting" sulfonamide characterized by its ability to produce prolonged detectable levels in the blood when given in relatively small doses once or twice a day. Neipp and Mayer49 have indicated that the solubility of this drug at pH 4.0 is greater than that of sulfisoxazole or sulfadiazine. Sulfisoxazole is more soluble than sulfamethoxypyridazine at pH 5.5.A number of illuminating studies of the absorption, excretion and blood concentrations of sulfamethoxypyridazine have been reported. Roepke et al.50 investigated these phenomena in dogs. They found that the administration of 50 mg. per kilogram of body weight . . .Keywords
This publication has 20 references indexed in Scilit:
- N1PACETYL SULFAMETHOXYPYRIDAZINEThe Lancet Healthy Longevity, 1958
- Prolonged Treatment of Urinary-Tract Infections with SulfamethoxypyridazineNew England Journal of Medicine, 1958
- Placental Transfer of SulfamethoxypyridazineNew England Journal of Medicine, 1957
- SULFAMETHOXYPYRIDAZINEThe Lancet Healthy Longevity, 1957
- EXPERIMENTAL INVESTIGATIONS OF SULFAMETHOXYPYRIDAZINEAnnals of the New York Academy of Sciences, 1957
- CLINICAL EXPERIENCE WITH SULFAMETHOXYPYRIDAZINEAnnals of the New York Academy of Sciences, 1957
- SULFAMETHOXYPYRIDAZINE: PHARMACOLOGICAL OBSERVATIONS AND CLINICAL USE IN THE TREATMENT OF URINARY TRACT INFECTIONSAnnals of the New York Academy of Sciences, 1957
- SULFAMETHOXYPYRIDAZINE AND SULFACHLOROPYRIDAZINEAnnals of the New York Academy of Sciences, 1957
- EXPERIMENTAL ACTIVITIES OF NEW SULFONAMIDESAnnals of the New York Academy of Sciences, 1957
- Sulfamethoxypyridazine: Preliminary Observations on Absorption and Excretion of a New, Long-Acting Antibacterial Sulfonamide.Experimental Biology and Medicine, 1956